Endo Pharmaceuticals
1400 Atwater Drive
Malvern
Pennsylvania
19355
United States
Tel: 484-216-0000
Website: http://www.endo.com/
305 articles about Endo Pharmaceuticals
-
Endo Pharmaceuticals Continues Expansion With $8.05 Billion Acquisition of Par Pharma
5/18/2015
-
Endo Pharmaceuticals And BioDelivery Sciences International Present Pivotal Data From Two Phase 3 Trials Demonstrating Safety And Efficacy Of Buprenorphine Hcl Buccal Film For The Management Of Chronic Pain
5/15/2015
-
Endo Pharmaceuticals Shells Out $130 Million for Nearly 70 Pipeline Programs From Aspen Pharmacare
5/11/2015
-
Braeburn Pharmaceutical Expands Pipeline To Include Schizophrenia With Endo Pharmaceuticals Deal
5/1/2015
-
Endo Pharmaceuticals Announces The Launch Of NATESTO (Testosterone Nasal Gel), The First And Only Nasal Gel For Testosterone Replacement Therapy
3/16/2015
-
Endo Pharmaceuticals And BioDelivery Sciences International Announce Acceptance Of NDA For BELBUCA (Buprenorphine Hcl) Buccal Film For The Management Of Chronic Pain
2/23/2015
-
BioDelivery Sciences International To Receive $10 Million Milestone Payment From Endo Pharmaceuticals In Conjunction With Acceptance Of NDA For BELBUCA (buprenorphine HCl) Buccal Film For Chronic Pain
2/23/2015
-
Endo Pharmaceuticals Rumored to be Battling Shire, Valeant for Salix's Affections
2/18/2015
-
Endo Pharmaceuticals To Announce Fourth Quarter 2014 Financial Results On March 2, 2015
2/13/2015
-
Endo Pharmaceuticals Completes Acquisition Of Auxilium Pharmaceuticals
1/30/2015
-
Endo Pharmaceuticals And BioDelivery Sciences International Announce NDA Submission For Buprenorphine Hcl Buccal Film For The Management Of Moderate To Severe Chronic Pain
12/24/2014
-
Endo Pharmaceuticals Completes Acquisition Of Rights To Natesto Testosterone Nasal Gel
12/9/2014
-
Endo Pharmaceuticals Announces Early Termination Of HSR Act Waiting Period In Connection With Its Proposed Acquisition Of Auxilium Pharmaceuticals
11/19/2014
-
Endo Pharmaceuticals Receives Final Approval For Generic Version Of Valcyte®
11/10/2014
-
Endo Pharmaceuticals Reports Third Quarter Financial Results
11/5/2014
-
Endo Pharmaceuticals To Announce Third Quarter 2014 Financial Results On November 5, 2014
10/21/2014
-
Auxilium Pharmaceuticals Institutes "Poison Pill" To Fend Off $2.2B Endo Pharmaceuticals Offer
9/17/2014
-
Endo Pharmaceuticals To Present At Morgan Stanley Global Healthcare Conference 2014
9/8/2014
-
Endo Boss Confident That New U.S. Rules Will Not Force Drugmaker Back Into America's Tax Regime
8/11/2014
-
Endo Pharmaceuticals Reports Second Quarter Financial Results
7/31/2014